Down Syndrome Market Trends and Drivers in 2025

NEW YORK - June 6, 2025 - PRLog -- The down syndrome market reached a value of USD 1.3 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 4.2 Billion by 2035, exhibiting a growth rate (CAGR) of 11.03% during 2025-2035.

Down syndrome, a genetic condition and disability, is the result of having an extra 21st chromosome. As a result, people affected by it may experience certain physical features, as well as intellectual and developmental delays. It is one of the most well-known chromosomal disorders, affecting about 1 in every 700 children born globally. Globally, prospects look promising for the Down syndrome market in 2025 and beyond, as more people are becoming aware of the condition. The market comprises all Down syndrome healthcare services, therapies, and other supportive treatments aimed at enhancing the patients' quality of life.

But one of the more notable factors that is likely to drive the Down syndrome market is the diagnosis and understanding of the condition itself. For a long time now, there has been increased support and advocacy of persons with Down syndrome. Social media, non-profits, and even government bodies have sought to improve stigmatization and educate people about the condition. This has also resulted in better attempts at diagnosing the condition early on, and providing appropriate intervention measures, such that people with Down syndrome are supported as early in life as possible.

Furthermore, improvement on prenatal screening and genetic tests has enabled health care professionals to easily detect Down syndrome during pregnancy. Such early identification is crucial in helping families and health care professionals prepare to optimally manage the condition. These diagnosis approaches are likely to continue being important in the market, leading to more genetic counseling and other healthcare services.

Request for a sample of this report: https://www.imarcgroup.com/down-syndrome-market/requestsample

Countries Covered:

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan

Competitive Landscape with key players:

The competitive landscape of the down syndrome market size (https://www.imarcgroup.com/down-syndrome-market) has been studied in the report with the detailed profiles of the key players operating in the market.
1. Eisai
2. AC Immune
3. Annovis Bio
4. Aelis Farma

Explore the Full Report with TOC: https://www.imarcgroup.com/request?type=report&id=6679&flag=A

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.